Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2005 Jul-Aug;57(4):465-8.

Use of a protease-modulating matrix in the treatment of pressure sores

Affiliations
  • PMID: 16060184
Clinical Trial

Use of a protease-modulating matrix in the treatment of pressure sores

Giuseppe Nisi et al. Chir Ital. 2005 Jul-Aug.

Abstract

Improved diagnostic and therapeutic possibilities lead to a higher incidence of chronic ulcerative lesions. Several sociological and nursing problems related to these pathologies have oriented the research towards new specific materials and methodologies in wound dressing. The main concept is to modulate the environment of wounds in order to reduce healing time, thus minimising costs and the incidence of disabling outcomes. The Authors report on their experience with the use of a protease-modulating matrix (Promogran) in the treatment of pressure sores. A cohort of 80 selected patients was randomly divided into two groups, one of which was treated with the test material, while the other was submitted to conventional dressings and used as a control group. A cost-effectiveness analysis was carried out. Compared to the controls, the treated group showed a lower mean healing time and a greater frequency of complete healing. The cost-effectiveness balance was found to be more advantageous in the treated group as well. Due to its reliability and absence of adverse reactions, the use of a matrix with a modulating action on proteases may represent an effective treatment in the management of cleansed chronic cutaneous losses.

PubMed Disclaimer

Publication types

Substances

LinkOut - more resources